Wright Medical Group NV

Wright Medical Group N.V. was founded in 1950 and is a global medical device company focused on Extremities and Biologics. The company specialises in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials. These include surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, which are considered three of the fastest-growing segments in orthopaedics. Company products include bone-conserving hip implants, advanced knee implants, revision replacement implants, and the integration of bio-orthopaedic products into reconstructive joint procedures and other orthopaedic applications. In November 2019, the company announced the Definitive Agreement to be Acquired by Stryker for a total equity value of approximately $4.7 billion, including Wright’s outstanding convertible notes, and total enterprise value of approximately $5.4 billion. The acquisition is expected to be completed in the second half of 2020. Wright Medical Group N.V. reported its financial results for the second quarter of fiscal 2019, which included net sales of $229.7 million. Diversify your portfolio and buy WMGI stocks.